OKYO Pharma Announces Chairman Acquires Shares

OKYO Pharma Announces Chairman Acquires Shares

by | 23rd August 2024 | News

London and New York, NY, August 23, 2024 – OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular...